Industrial Technology Research Institute

A method and a device for communication operation are provided. In the method, a first signaling for activating a first transmission of a first Synchronization Signal/Physical Broadcast Channel Block, SSB, is received, and the first transmission of the first SSB is received according to the first signaling.

Transmission apparatus and method, receiving apparatus and method are provided. The transmission apparatus generates neighbor network information based on a communication protocol corresponding to a communication satellite. The transmission apparatus transmits a mediate packet including the neighbor network information to the receiving apparatus. The receiving apparatus obtains a second header, based on a first header and the neighbor network information of the mediate packet. The receiving apparatus transmits a forwarded packet to the communication satellite based on the communication protocol, wherein the forwarded packet includes the second header and data of the mediate packet.

A method and a user equipment, UE, (1100) served by a serving node in a Non-Terrestrial Network, NTN, are provided. In the method, a measurement configuration is received, and one or more target SSB measurement timing configurations, SMTCs, from multiple SMTCs are selected. The measurement configuration includes the multiple SMTCs.

An alkyl bisphenol composition and a method for preparing the same are provided. The alkyl bisphenol composition includes 99.85wt% to 99.999wt% of an alkyl bisphenol; 0.0001wt% to 0.01wt% of a monophenolic compound; 0.0001wt% to 0.01wt% of a reaction adduct of alkyl bisphenol; and 0.0001wt% to 0.1497wt% of an aromatic compound, wherein the aromatic compound is not the alkyl bisphenol, the monophenolic compound, or the reaction adduct of alkyl bisphenol.

An eye drop platform for delivering active ingredients to anterior chamber tissue and/or posterior chamber tissue of eye is provided. The eye drop platform for delivering active ingredients to anterior chamber tissue and/or posterior chamber tissue of eye includes a delivery composition and a pharmaceutically acceptable solvent for dissolving the delivery composition to form a solution as the eye drop platform for delivering active ingredients to anterior chamber tissue and/or posterior chamber tissue of eye. The delivery composition includes cyclodextrin and/or a derivative thereof, and caffeine. The concentration of the cyclodextrin and/or the derivative thereof in the solution ranges from 5-500 mg/mL, and the concentration of the caffeine in the solution ranges from 0.5-50 mg/mL. The active ingredient is a hydrophilic compound, and the hydrophilic compound has a water solubility greater than 1 mg/mL.

A multi-feed antenna (1) includes first and second conductor layers (11, 21) and slit structures (131, 132). The first and second conductor layers are spaced apart at a first interval. The second conductor layer has a center slot structure (121). The slit structures are all formed at the second conductor layer, wherein each has a first end connecting with the center slot structure and a second end respectively extending to different side edges of the second conductor layer. The slit structures make the second conductor layer form radiating conductor plates. A total number of the slit structures equals to a total number of the radiating conductor plates. Each radiating conductor plate is electrically connected or electrically coupled to at least one signal source. Each signal source respectively excites the second conductor layer to generate at least one resonant mode. The resonant modes cover at least one identical first communication band.

An implant is provided, and the implant includes a body, a limiting portion and a filling portion. The body has a first end portion, a second end portion opposite to the first end portion, and a middle portion disposed between the first end portion and the second end portion. The limiting portion includes a first solid structure and is located at the first end portion. The filling part includes an elastic structure and is located from the middle portion to the second end portion. A diameter of the first end portion of the body is greater than a diameter of the middle portion, and a diameter of the second end portion is greater than the diameter of the middle portion.

A method for processing a physiological signal is provided. The method includes the following steps. A standard physiological signal as a first template to perform a first match filtering on an original physiological signal of a subject under test is used, thereby obtaining a first filtered physiological signal. A correlation evaluation on the first filtered physiological signal is performed and based on an evaluation result, whether interference has been sufficiently eliminated is determined. When determining that the interference has not been sufficiently eliminated, a personal physiological signal of the subject under test is used as a second template to perform a second match filtering on the first filtered physiological signal, thereby obtaining a second filtered physiological signal. A physiological parameter of the subject under test based on the second filtered physiological signal is generated.

An imaging element cleaning device for cleaning a lens of an imaging element is provided, including a cleaning element and a driving component. The cleaning element includes a flexible sleeve that is hollow and includes a distal end and a proximal end opposite to the distal end, a cleaning part partially covering the distal end of the flexible sleeve, and a slit part penetrating through the cleaning part. The driving component includes a tube, which includes a distal end and a proximal end opposite to the distal end for the imaging element to pass through, and the flexible sleeve of the cleaning element is sleeved on the distal end of the tube, wherein when the driving component is driven to move the cleaning element, the lens of the imaging element passes through the slit part to be cleaned by the cleaning part.

A compound or a salt thereof is provided. The compound has a structure represented by Formula (I), Formula (II) or Formula (III): <img class="EMIRef" id="7f2c4b8f-582e-42a8-90ef-d95de9c572b7-ia01" /> <img class="EMIRef" id="7f2c4b8f-582e-42a8-90ef-d95de9c572b7-ia02" /> and <img class="EMIRef" id="7f2c4b8f-582e-42a8-90ef-d95de9c572b7-ia03" />